115 results on '"Wyeth -- Mergers, acquisitions and divestments"'
Search Results
2. American Home plans to reduce stake in Immunex with $2,7 billion stock sale
3. Pact for Cyanamid unit of American Home is set
4. BASF nears pact for AHP's Cyanamid
5. Pfizer, Warner-Lambert agree on terms
6. Warner-Lambert takes higher Pfizer bid; tentative pact now hinges on negotiating breakup with American Home
7. Pfizer, Warner-Lambert move closer to merger terms
8. Is Pharmacia merger just a prelude?
9. After P&G, what's next in Pfizer war?
10. P&G walks away from merger talks; stock decline prompts end to Warner-AHP link; bidder Pfizer bolstered
11. P&G board may discuss drug-firm deal
12. Drug firms press Warner-Lambert deal
13. Warner-Lambert held talks with P&G
14. American Home may seek Warner-Lambert, Pfizer product rights
15. Warner-Lambert concedes Pfizer bid may be better than an AHP merger
16. Warner-Lambert tactics are questioned
17. Warner-Lambert defends its decision on AHP deal in letter to shareholders
18. AHP offers to pay Warner holders if the company gets control of Lipitor
19. Pfizer sues Warner over Lipitor accord
20. Warner-Lambert suit against Pfizer could backfire, experts say
21. Warner-Lambert is moving to decision on possible legal action against Pfizer
22. Pfizer covets Warner's labs, research staff
23. Is Warner-Lambert defense playing fair?
24. Pfizer assails rivals' plan for merger
25. Warner-Lambert fires volley at Pfizer
26. Pfizer will tout new drugs in effort to rebut analysts' doubts about bid
27. Drug-industry merger wave heads to Europe; while U.S. is attractive, weak margins, growth may keep firms home
28. American Home's shareholders may win even if firm loses bid
29. The pharmaceutical revolution
30. Pfizer may drop Warner-bid conditions
31. Warner-Lambert option to end venture may have played a role in Pfizer's bid
32. Anatomy of a drug merger: how two leaders courted and struck
33. Tactic of granting options faces big test in court
34. Mixing it up: in biggest hostile bid, Pfizer offers $80 billion for Warner-Lambert; it acts as target confirms its own plan to merge with American Home; coveting a hot heart drug
35. With executives aging and patents expiring, industry is ripe for megamergers
36. Rx for drug companies: get hitched, stat! Boards of Warner-Lambert, American Home agree on $72 billion stock transaction
37. AHP, Warner-Lambert discuss merger; transaction for $65 billion could spur consolidation among drug companies
38. Glaxo, American Home pact
39. Monsanto put options are active as investors seek protection after merger plan is cancelled
40. Colgate-Palmolive Co
41. Colgate to buy oral-care line in Latin America; American Home to receive $1.04 billion for business in fast-growing market
42. American Home will spin off business in vaccines in antitrust pact with FTC
43. American Home Products
44. American Home delays purchase
45. American Home and Cyanamid
46. Tender offer for Cyanamid is extended in FTC pact
47. American Home's Cyanamid conquest spawned fat fees; firms' investment bankers received $57.6 million for two-week struggle
48. FTC asks Cyanamid and American Home for additional data
49. In takeover of Cyanamid, shareholders are winners, but workers stand to lose
50. American Cyanamid agrees to takeover by American Home in $9.7 billion accord; maker of prescription drugs to be U.S.'s 4th largest; price set at $101 a share
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.